Related Experiment Videos
Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer
Ken-Ichi Takayama1, Kuniko Horie-Inoue, Shintaro Katayama
1Department of Anti-Aging Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
The EMBO Journal
|May 7, 2013
Summary
A novel long non-coding RNA, CTBP1-AS, drives prostate cancer growth by repressing tumor suppressors and promoting cell cycle progression. This finding reveals new therapeutic targets for prostate cancer.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- High-throughput screening has identified numerous antisense (AS) transcripts and long non-coding RNAs (ncRNAs), yet their roles in cancer remain largely uncharacterized.
- Prostate cancer progression is linked to complex regulatory mechanisms involving non-coding RNAs.
Purpose of the Study:
- To investigate the role of a specific androgen-responsive long ncRNA, CTBP1-AS, in prostate cancer development and progression.
- To elucidate the molecular mechanisms by which CTBP1-AS influences tumor growth and gene expression.
Main Methods:
- Identification and characterization of CTBP1-AS in prostate cancer tissues.
- Analysis of CTBP1-AS expression levels and localization (nuclear).
- Investigating the mechanistic role of CTBP1-AS in regulating CTBP1 expression and tumor suppressor genes, involving PSF and histone deacetylases.
Main Results:
- CTBP1-AS expression is upregulated in prostate cancer and promotes both hormone-dependent and castration-resistant tumor growth.
- CTBP1-AS directly represses CTBP1 expression by recruiting PSF and histone deacetylases.
- CTBP1-AS globally inhibits tumor-suppressor genes via a PSF-dependent mechanism, promoting cell cycle progression.
Conclusions:
- CTBP1-AS is a key driver of prostate cancer progression.
- CTBP1-AS represents a potential therapeutic target for prostate cancer treatment.
- This study highlights the significant role of ncRNAs in cancer biology and provides new insights into prostate cancer pathogenesis.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...